PMC:7335494 / 36315-36605 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T288","span":{"begin":17,"end":29},"obj":"Body_part"},{"id":"T289","span":{"begin":175,"end":187},"obj":"Body_part"},{"id":"T290","span":{"begin":212,"end":224},"obj":"Body_part"}],"attributes":[{"id":"A288","pred":"fma_id","subj":"T288","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A289","pred":"fma_id","subj":"T289","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A290","pred":"fma_id","subj":"T290","obj":"http://purl.org/sig/ont/fma/fma82737"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T126","span":{"begin":237,"end":240},"obj":"Disease"},{"id":"T128","span":{"begin":242,"end":245},"obj":"Disease"}],"attributes":[{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0008966"},{"id":"A127","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0019480"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0008966"},{"id":"A129","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0019480"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T369","span":{"begin":74,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T370","span":{"begin":146,"end":148},"obj":"http://purl.obolibrary.org/obo/CL_0000453"},{"id":"T371","span":{"begin":167,"end":169},"obj":"http://purl.obolibrary.org/obo/CL_0000453"},{"id":"T372","span":{"begin":204,"end":206},"obj":"http://purl.obolibrary.org/obo/CL_0000453"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T450","span":{"begin":146,"end":148},"obj":"Chemical"},{"id":"T451","span":{"begin":167,"end":169},"obj":"Chemical"},{"id":"T452","span":{"begin":175,"end":187},"obj":"Chemical"},{"id":"T453","span":{"begin":204,"end":206},"obj":"Chemical"},{"id":"T454","span":{"begin":212,"end":224},"obj":"Chemical"}],"attributes":[{"id":"A450","pred":"chebi_id","subj":"T450","obj":"http://purl.obolibrary.org/obo/CHEBI_73582"},{"id":"A451","pred":"chebi_id","subj":"T451","obj":"http://purl.obolibrary.org/obo/CHEBI_73582"},{"id":"A452","pred":"chebi_id","subj":"T452","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A453","pred":"chebi_id","subj":"T453","obj":"http://purl.obolibrary.org/obo/CHEBI_73582"},{"id":"A454","pred":"chebi_id","subj":"T454","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T194","span":{"begin":0,"end":132},"obj":"Sentence"},{"id":"T195","span":{"begin":133,"end":155},"obj":"Sentence"},{"id":"T196","span":{"begin":156,"end":192},"obj":"Sentence"},{"id":"T197","span":{"begin":193,"end":290},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}

{"project":"MyTest","denotations":[{"id":"32640331-28759939-30720848","span":{"begin":285,"end":289},"obj":"28759939"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}

{"project":"2_test","denotations":[{"id":"32640331-28759939-30720848","span":{"begin":285,"end":289},"obj":"28759939"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T2088","span":{"begin":137,"end":168},"obj":"CHEBI:16113;CHEBI:16113"}],"text":"Low-Calorie, Low-Carbohydrate Soy Diet Parallel randomized clinical trial 45 patients with NAFLD 8-week diet intervention:➢ Group 1: Low-calorie (LC) diet,\n➢ Group 2: LC, low-carbohydrate diet\n➢ Group 3: LC, low-carbohydrate diet + soy (LCS) LCS: ↓ glycaemic indices, CRP Kani et al. (2017)"}